Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc.

IPIX
Innovation Pharmaceuticals Inc.US flagOther OTC
0.00
USD
- -
- -
155,504.00Market Cap

Income Statement (USD)

APIChatGPT
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
06/30/2009
06/30/2010
06/30/2011
06/30/2012
06/30/2013
06/30/2014
06/30/2015
06/30/2016
06/30/2017
06/30/2018
06/30/2019
06/30/2020
06/30/2021
06/30/2022
06/30/2023
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
1
3
6
4
3
8
13
12
15
14
6
5
9
7
3
+ Selling, General & Admin
1
1
4
4
1
2
2
3
3
3
2
2
2
2
1
+ Research & Development
- -
2
1
1
2
6
11
9
13
11
4
3
7
5
1
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
-3
-6
-4
-3
-8
-13
-12
-15
-14
-6
-5
-9
-7
-3
- Non-Operating (Income) Loss
- -
- -
- -
1
- -
- -
- -
1
- -
2
2
2
5
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
5
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
5
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
1
- -
2
- -
2
- -
- -
- -
Pretax Income
-1
-3
-6
-5
-3
-8
-13
-13
-16
-16
-9
-7
-14
-7
-3
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-3
-6
-5
-3
-8
-13
-13
-16
-16
-9
-7
-14
-7
-3
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-3
-6
-5
-3
-8
-13
-13
-16
-16
-9
-7
-14
-7
-3
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-3
-6
-5
-3
-8
-13
-13
-16
-16
-9
-7
-14
-7
-3
- Preferred Dividends
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-3
-6
-5
-3
-10
-13
-13
-16
-16
-9
-7
-14
-7
-3
EBIT
-1
-3
-6
-4
-3
-8
-13
-12
-15
-14
-6
-5
-9
-7
-3
EBITDA
-1
-3
-6
-4
-3
-8
-13
-12
-15
-14
-6
-4
-9
-6
-3
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,007.57
- -
-35,422.22
- -
EBITA
-1
-3
-6
-4
-3
-8
-13
-12
-15
-14
-6
-5
-9
-7
-3
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
100
- -
100
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,095.74
- -
-37,544.44
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,571.63
- -
-39,116.67
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
92
92
90
90
95
105
115
120
127
145
178
238
386
504
506
Basic EPS, GAAP
-0.02
-0.04
-0.07
-0.06
-0.04
-0.1
-0.11
-0.11
-0.12
-0.11
-0.05
-0.03
-0.04
-0.01
-0.01
Basic EPS from Cont Ops
-0.02
-0.04
-0.07
-0.05
-0.03
-0.08
-0.11
-0.11
-0.12
-0.11
-0.05
-0.03
-0.04
-0.01
-0.01
Diluted Weighted Avg Shares
92
92
90
90
95
105
115
120
127
145
178
238
386
504
506
Diluted EPS, GAAP
-0.02
-0.04
-0.07
-0.06
-0.04
-0.1
-0.11
-0.11
-0.12
-0.11
-0.05
-0.03
-0.04
-0.01
-0.01
Diluted EPS from Cont Ops
-0.02
-0.04
-0.07
-0.05
-0.03
-0.08
-0.11
-0.11
-0.12
-0.11
-0.05
-0.03
-0.04
-0.01
-0.01

Balance Sheet (USD)

APIChatGPT
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
06/30/2009
06/30/2010
06/30/2011
06/30/2012
06/30/2013
06/30/2014
06/30/2015
06/30/2016
06/30/2017
06/30/2018
06/30/2019
06/30/2020
06/30/2021
06/30/2022
06/30/2023
Total Current Assets
- -
- -
- -
- -
3
6
9
7
4
3
1
6
11
4
2
+ Cash, Cash Equivalents & STI
- -
- -
- -
- -
3
5
8
6
4
2
1
6
10
4
2
+ Cash & Cash Equivalents
- -
- -
- -
- -
3
5
8
6
4
2
1
6
10
4
2
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
5
6
5
5
4
3
3
4
6
6
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
4
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
4
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
5
6
5
5
4
3
3
4
2
2
+ Total Intangible Assets
- -
- -
- -
- -
- -
5
5
4
4
4
3
3
3
2
2
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
5
5
4
4
4
3
3
3
2
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
Total Assets
- -
- -
- -
- -
3
11
14
11
9
7
4
9
14
10
8
+ Payables & Accruals
2
2
5
5
6
3
5
6
8
6
5
5
5
4
5
+ Accounts Payable
- -
1
- -
2
- -
3
2
4
5
3
2
2
3
3
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
4
3
6
- -
3
3
4
3
3
3
2
2
2
+ ST Debt
- -
- -
- -
- -
2
2
2
2
2
2
2
2
2
- -
- -
+ ST Borrowings
- -
- -
- -
- -
2
2
2
2
2
2
2
2
1
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
2
2
3
- -
5
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
2
2
3
- -
5
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
2
5
7
7
8
10
7
8
11
9
7
7
7
5
5
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
- -
Total Noncurrent Liabilities
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
- -
Total Liabilities
2
5
8
8
8
10
7
8
11
9
8
8
7
6
5
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
5
9
15
29
48
57
68
84
91
103
125
129
130
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
5
9
15
29
48
57
68
84
91
103
125
129
130
- Treasury Stock
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
+ Retained Earnings
-2
-5
-11
-16
-20
-28
-41
-54
-70
-86
-95
-101
-115
-122
-125
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-2
-5
-7
-8
-5
1
7
3
-1
-2
-4
1
8
5
2
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-2
-5
-7
-8
-5
1
7
3
-1
-2
-4
1
8
5
2
Total Liabilities & Equity
- -
- -
- -
- -
3
11
14
11
9
7
4
9
14
10
8
Shares Outstanding
92
92
88
92
99
110
118
124
135
163
203
331
434
504
518
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
Net Debt
- -
- -
- -
- -
-1
-3
-6
-4
-2
- -
1
-4
-9
-4
-1
Net Debt to Equity
-16.28
-9.5
-6.14
0.36
18.05
-245.94
-90.95
-144.67
144.74
18.69
-32.53
-281.6
-116.38
-75.2
-64
Tangible Common Equity Ratio
-1,155.08
-4,711.86
-2,327.75
-27,208.5
-175
-63.77
21.57
-18.88
-115.84
-214.81
-1,061.22
-25.82
41.19
29.97
0.72
Current Ratio
0.08
0.02
0.05
- -
0.36
0.58
1.2
0.78
0.42
0.3
0.09
0.83
1.63
0.82
0.33
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
06/30/2009
06/30/2010
06/30/2011
06/30/2012
06/30/2013
06/30/2014
06/30/2015
06/30/2016
06/30/2017
06/30/2018
06/30/2019
06/30/2020
06/30/2021
06/30/2022
06/30/2023
+ Net Income
-1
-3
-6
-5
-3
-8
-13
-13
-16
-16
-9
-7
-14
-7
-3
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
3
3
1
1
- -
1
1
4
3
2
5
1
- -
+ Stock-Based Compensation
- -
- -
3
3
- -
1
- -
1
1
2
1
- -
- -
1
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
1
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
1
- -
- -
- -
- -
- -
2
2
1
5
- -
- -
+ Chg in Non-Cash Work Cap
1
2
2
1
1
- -
-1
1
2
-2
-1
- -
-1
- -
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
1
2
1
1
- -
-1
1
2
-2
-1
- -
- -
-1
- -
+ Inc (Dec) in Other
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-1
-1
-1
-2
-8
-13
-10
-12
-13
-6
-4
-9
-6
-2
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
-3
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
-3
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
4
10
16
8
10
12
- -
- -
4
- -
- -
+ Increase in Capital Stock
- -
- -
- -
- -
4
10
16
8
10
12
- -
- -
5
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
-3
- -
- -
- -
- -
- -
- -
- -
-4
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
+ Cash From Debt
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
+ Other Financing Activities
- -
- -
- -
1
- -
2
1
- -
- -
- -
5
10
10
6
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
1
1
1
5
12
17
8
10
12
5
10
14
4
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
- -
3
2
3
-2
-2
-2
-2
5
4
-6
-2
EBITDA
-1
-3
-6
-4
-3
-8
-13
-12
-15
-14
-6
-4
-9
-6
-3
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,007.57
- -
-35,422.22
- -
Free Cash Flow
- -
-1
-1
-1
-2
-10
-14
-10
-12
-13
-6
-4
-10
-6
-2
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
- -
-1
-2
-10
-13
-10
-12
-13
-6
-4
-10
-8
-2
Free Cash Flow per Basic Share
- -
-0.01
-0.01
-0.01
-0.02
-0.1
-0.12
-0.09
-0.09
-0.09
-0.04
-0.02
-0.02
-0.01
- -
Price/Free Cash Flow
-165.03
-44.72
-89.6
-41.57
-16.03
-36.27
-23.54
-17.59
-10.74
-6.48
-5.34
-24.05
-8.83
-2.49
-4.8
Cash Flow to Net Income
0.14
0.32
0.12
0.14
0.59
0.91
0.99
0.77
0.75
0.81
0.73
0.63
0.68
0.89
0.66
Capital Expenditures
- -
- -
- -
- -
- -
-3
- -
- -
- -
- -
- -
- -
- -
- -
- -